19.13

1.32% 0.25

Castle Biosciences Inc (CSTL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CSTL Giù? Forum Previsione

Precedente Chiudi:

$18.88

Aprire:

$18.69

Volume 24 ore:

554.91K

Relative Volume:

1.40

Capitalizzazione di mercato:

$580.21M

Reddito:

$344.23M

Utile/perdita netta:

$-24.16M

Rapporto P/E:

-22.58

EPS:

-0.8471

Flusso di cassa netto:

$28.33M

1 W Prestazione:

-3.53%

1M Prestazione:

-22.30%

6M Prestazione:

-42.81%

1 anno Prestazione:

+16.08%

Intervallo 1D:

$18.64

$19.61

Intervallo di 1 settimana:

$17.72

$19.98

Portata 52W:

$14.59

$44.28

Castle Biosciences Inc Stock (CSTL) Company Profile

Nome

Castle Biosciences Inc

Settore

Healthcare (1101)

Industria

Diagnostics & Research (52)

Telefono

866-788-9007

Indirizzo

1500 W. PARKWOOD AVE., FRIENDSWOOD, TX

Dipendente

942

Cinguettio

@castlebio

Prossima data di guadagno

2026-05-06

Ultimi documenti SEC

CSTL's Discussions on Twitter

Compare CSTL vs TMO, DHR, IDXX, WAT, A

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CSTL Castle Biosciences Inc	19.13	572.63M	344.23M	-24.16M	28.33M	-0.8471
TMO Thermo Fisher Scientific Inc	438.34	166.56B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	161.91	116.46B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	528.79	42.03B	4.45B	1.10B	1.06B	13.59
WAT Waters Corp	329.22	32.72B	3.77B	449.25M	240.68M	7.8556
A Agilent Technologies Inc	111.70	32.01B	7.07B	1.29B	993.00M	4.5355

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-14	Iniziato	Guggenheim	Buy
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-01-07	Iniziato	Stephens	Overweight
2021-04-30	Iniziato	Lake Street	Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2019-12-27	Reiterato	Canaccord Genuity	Buy
2019-08-19	Iniziato	BTIG Research	Buy
2019-08-19	Iniziato	Canaccord Genuity	Buy
2019-08-19	Iniziato	Robert W. Baird	Outperform
2019-08-19	Iniziato	SVB Leerink	Outperform

Mostra tutto

Castle Biosciences Inc Borsa (CSTL) Ultime notizie

May 15, 2026

Portolan Capital amends Castle Biosciences (NASDAQ: CSTL) 13G; 4.45% stake reported - Stock Titan

May 15, 2026

Castle Biosciences, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:CSTL) 2026-05-13 - Seeking Alpha

May 13, 2026

META_TITLE_QUOTE - Yahoo Finance

May 13, 2026

CSTL Maintained by BTIG -- Price Target Lowered to $40.00 - GuruFocus

May 13, 2026

BTIG lowers Castle Biosciences stock price target on higher costs By Investing.com - Investing.com India

May 13, 2026

BTIG Research Has Lowered Expectations for Castle Biosciences (NASDAQ:CSTL) Stock Price - MarketBeat

May 13, 2026

BTIG lowers Castle Biosciences stock price target on higher costs - Investing.com UK

May 13, 2026

Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference - PR Newswire

May 13, 2026

May 12, 2026

Castle Biosciences recognized for driving progress in global healthcare with AdvanceAD-Tx accolade - Traders Union

May 12, 2026

Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation - Nasdaq

May 12, 2026

Price-Driven Insight from (CSTL) for Rule-Based Strategy - Stock Traders Daily

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

Derek Maetzold, Castle Biosciences CEO, sells $217,904 in shares By Investing.com - Investing.com Australia

May 11, 2026

Derek Maetzold, Castle Biosciences CEO, sells $217,904 in shares - Investing.com

May 11, 2026

Castle Biosciences (CSTL) CEO sells shares and exercises stock options in pre-planned trades - Stock Titan

May 11, 2026

May 09, 2026

Castle Biosciences (NASDAQ:CSTL) Cut to "Sell" at Wall Street Zen - MarketBeat

May 09, 2026

May 08, 2026